69,00€
The Dermastir Leave-in mask is to be applied after the day or night cream and this is done so that the ingredients in the creams remain for a longer time in the skin. 50 ml.
Packaging / Volume | 50 ml |
---|---|
Classification of cosmetics by purpose | For face and body care |
Type of cosmetics | Masks |
Apply the leave-in face mask immediately after applying the day and night cream or after any type of serum. The leave-in face mask can be left in till the next morning if applied after a night cream and it does not need to be washed off. For all skin types.
Aqua, glycerin, hydrogenated didecene, cyclopentasiloxane, butylene glycol, polysorbate 20, dimethicone, betaine, peg- 240/hdi copolymer bis-decyltetradeceth-20 ether, cyclomethicone, 1,2-hexanediol, arctium lappa root extract, bisabolol, phellinus linteus extract, phenoxyethanol, dimethicone/vinyl dimethicone crosspolymer, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, squalene, hydrogenated lecithin, piper methysticum leaf/root/stem extract, portulaca oleracea extract, pueraria thunbergiana root extract, cnidium officinale root extract, glycyrrhiza glabra root extract, paeonia lactiflora root extract, soluble collagen, parfum, xanthan gum, ethylhexylglycerin, tocopheryl acetate, aloe barbadensis leaf juice, neopentyl glycol diheptanoate, tocopheryl linoleate, benzophenone-4, polysorbate 60, sucrose distearate, adenosine, disodium edta, triethanolamine, ceramide 3, sodium hyaluronate, folic acid, ci 19140, cholesterol, raffinose, tromethamine, palmitoyl pentapeptide-4, panthenol
The Dermastir Leave-in mask is to be applied after the day or night cream and this is done so that the ingredients in the creams remain for a longer time in the skin. With age the skin becomes thinner and therefore it is more difficult for the skin to keep ingredients and hydration in the skin. Using medical terminology one may say that the Dermastir Leave-in masks helps to decrease the trans epidermal water loss (TEWL).
STARPTAUTISKĀS KONKURĒTSPĒJAS VEICINĀŠANAI
SIA “Flebomedika” ir noslēdzis 2016. Gada 16. Septembrī līgumu Nr.SKV-L_2016/785 ar Latvijas Investīciju un attīstības aģentūru par atbalsta saņemšanu pasākuma « Starptautiskās konkurētspējas veicināšana » ietvaros, ko līdzfinansē Eiropas Reģionālās attīstības fonds